Stockscreener 앱 받기
153.83
1.24%
1.89
시간 외 거래:
153.83
Becton Dickinson Co 주식(BDX)의 최신 뉴스
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
XS283900436 Bond Profile — Key Metrics - TradingView
BD Korea expands BD Aptra portfolio with launch of single-use digital flexible cystoscope in Korea - koreabiomed.com
Becton, Dickinson and Company stock: Is BDX underperforming the healthcare sector? - MSN
Evercore Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $180 - 富途牛牛
Becton Dickinson & Co highlights its medical technology footprint as a global healthcare supplier - Ad Hoc News
A Look at Becton Dickinson & Co (BDX) After 3.7% Decline -- GF V - GuruFocus
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Becton Dickinson (BDX) Following Its Veritor Shift And Index Changes Looks Undervalued - simplywall.st
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom - The Motley Fool
Becton, Dickinson and (NYSE:BDX) Releases FY23 Earnings Guidance - 富途牛牛
Becton Dickinson and Co steadies operations as healthcare demand evolves - ad-hoc-news.de
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Form 4 Becton Dickinson and Co For: 6 July By Investing.com - Investing.com Canada
Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190 - Moomoo
Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating Growth Potential and Analyst Ratings - DirectorsTalk Interviews
Does Vizient’s CentroVena One Deal and Index Shuffle Change The Bull Case For Becton Dickinson (BDX)? - simplywall.st
Becton Dickinson stock gains after company lifts earnings outlook By Investing.com - Investing.com Nigeria
Becton Dickinson & Co (BDX) Stock Forum and Discussion - Moomoo
Becton Dickinson stock holds its setup. Focus shifts to business fundamentals. - AD HOC NEWS
Is It Too Late to Buy Becton Dickinson & Co (BDX) After 3.4% Ral - GuruFocus
Becton Dickinson holds steady as investors await a fresh catalyst - AD HOC NEWS
Becton, Dickinson and Company: Now Is A Great Time To Buy (NYSE:BDX) - Seeking Alpha
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion System - Insider Monkey
List of 36 Acquisitions by Becton Dickinson (Jul 2026) - Tracxn
Becton Dickinson (NYSE:BDX) Advances in NYSE Composite After Vizient Deal - Kalkine Media
Becton Dickinson (BDX) Wins Vizient Contract As Fair Value Stays In Focus - simplywall.st
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Becton Dickinson updates fiscal 2026 outlook, shares steady after cautious guidance - AD HOC NEWS
Form 4 Becton Dickinson and Co For: 26 June By Investing.com - Investing.com India
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Michael Feld sells $11,460 of Becton Dickinson stock - Investing.com
Becton Dickinson & Co (BDX) Stock Up 3.0% and Still Undervalued -- GF Score: 76/100 - GuruFocus
Becton Dickinson EVP sells $160,226 in BDX shares By Investing.com - Investing.com South Africa
Becton Dickinson EVP sells $160,226 in BDX shares - Investing.com UK
AQR Trend Total Return Fund's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Form 4 Becton Dickinson and Co For: 25 June By Investing.com - Investing.com Australia
Insider Sell: Michael Garrison Sells 1,100 Shares of Becton Dick - GuruFocus
Becton Dickinson and Co (BDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BD’s central line system gets Vizient’s innovation seal - Stock Titan
Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products - Insider Monkey
1.12%
1.75%
자본화:
|
볼륨(24시간):